• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIX1通过ZEB1/IL6/STAT3信号轴传递乳腺癌进展信号。

SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis.

作者信息

Guo Liantao, Rao Yan, Song Yawen, Hu Jiawei, Luo Zixuan, Sun Shengrong, Chen Chuang, Kong Deguang

机构信息

Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Animal Biosafety Level III Laboratory at the Center for Animal Experiment, Wuhan University School of Medicine, Wuhan, Hubei, China.

出版信息

Oncogene. 2025 Jul 26. doi: 10.1038/s41388-025-03499-6.

DOI:10.1038/s41388-025-03499-6
PMID:40715465
Abstract

Epithelial-mesenchymal transition (EMT) and breast cancer stem cells (BCSCs) are pivotal in breast cancer mechanism research. It was demonstrated that Sine oculis homeobox homolog 1 (SIX1) orchestrates breast cancer EMT and BCSCs, concurrently activating the Signal transducer and activator of transcription 3 (STAT3) signaling pathway. Yet, the mechanism by which SIX1 modulates STAT3 and its potential to regulate EMT and BCSCs through STAT3 signaling remain unexplored. Here, cellular, animal, organoid models, and integrated single-cell transcriptomic and ST-seq of human breast cancer specimens were conducted. The results revealed that SIX1 can enhance Zinc finger E-box binding homeobox 1 (ZEB1) expression and translation, which in turn binds to the Interleukin-6 (IL6) promoter (1138bp-1148bp) to stimulate its transcription, translation, and secretion. Subsequently, IL6 can activate the cell's own STAT3 signaling pathway, promote the phosphorylation of STAT3, promote the downstream signal c-Myc and Cyclin D1 transduction, and promote the expression of stem cell-related transcription factors such as ALDH1A1, OCT4, and SOX2, thereby promoting EMT and stemness. In addition, this study found a new cell interaction model, in which the above-mentioned secreted IL6 can promote the activation of STAT3 signaling pathway, EMT and stemness transformation in the surrounding cells with low expression of SIX1 in a paracrine manner. Our data favored that SIX1/ZEB1/IL6 axis activated the STAT3 signaling pathway of the breast cells themselves and surrounding cells with low SIX1 expression, thus promoting EMT and stemness transformation, activating the malignant progression of the whole breast cancer.

摘要

上皮-间质转化(EMT)和乳腺癌干细胞(BCSCs)在乳腺癌机制研究中至关重要。研究表明,无眼同源盒1(SIX1)协调乳腺癌的EMT和BCSCs,同时激活信号转导和转录激活因子3(STAT3)信号通路。然而,SIX1调节STAT3的机制及其通过STAT3信号通路调节EMT和BCSCs的潜力仍未得到探索。在此,进行了细胞、动物、类器官模型以及人类乳腺癌标本的单细胞转录组和空间转录组测序(ST-seq)整合分析。结果显示,SIX1可增强锌指E盒结合同源盒1(ZEB1)的表达和翻译,ZEB1进而与白细胞介素6(IL6)启动子(1138bp - 1148bp)结合,刺激其转录、翻译和分泌。随后,IL6可激活细胞自身的STAT3信号通路,促进STAT3磷酸化,促进下游信号c-Myc和细胞周期蛋白D1的转导,并促进干细胞相关转录因子如醛脱氢酶1A1(ALDH1A1)、八聚体结合转录因子4(OCT4)和性别决定区Y框蛋白2(SOX2)的表达,从而促进EMT和干性。此外,本研究发现了一种新的细胞相互作用模型,其中上述分泌的IL6能够以旁分泌方式促进周围SIX1低表达细胞中STAT3信号通路的激活、EMT和干性转化。我们的数据表明,SIX1/ZEB1/IL6轴激活了乳腺癌细胞自身以及周围SIX1低表达细胞的STAT3信号通路,从而促进EMT和干性转化,激活整个乳腺癌的恶性进展。

相似文献

1
SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis.SIX1通过ZEB1/IL6/STAT3信号轴传递乳腺癌进展信号。
Oncogene. 2025 Jul 26. doi: 10.1038/s41388-025-03499-6.
2
MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6/JAK2/STAT3 Axis in Pancreatic Cancer.MCPIP1通过IL6/JAK2/STAT3轴调控胰腺癌中的混合上皮-间质转化和肿瘤干性。
Cancer Med. 2025 Sep;14(17):e71179. doi: 10.1002/cam4.71179.
3
Regulation of divergent epithelial-to-mesenchymal transition responses via the CDK4/6-USP51 pathway through ZEB1 protein stabilization.通过CDK4/6-USP51途径稳定ZEB1蛋白来调控不同的上皮-间质转化反应。
Sci Rep. 2025 Aug 29;15(1):31802. doi: 10.1038/s41598-025-17310-9.
4
High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.高 B3GALT5 表达预示不良临床结局,并促进乳腺癌的肿瘤进展和转移。
Breast Cancer Res. 2021 Jan 7;23(1):5. doi: 10.1186/s13058-020-01381-9.
5
Suppresses Colorectal Cancer Progression by Inhibiting Epithelial-Mesenchymal Transition via Regulation.通过调控抑制上皮-间质转化来抑制结直肠癌进展
Oncol Res. 2025 Aug 28;33(9):2379-2398. doi: 10.32604/or.2025.063501. eCollection 2025.
6
Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.IL6 的 N-糖基化缺陷导致肺癌转移和酪氨酸激酶抑制剂耐药。
Nat Commun. 2024 Sep 9;15(1):7885. doi: 10.1038/s41467-024-51831-7.
7
DSG3 promotes bladder cancer growth and metastasis via AKT/GSK3β/β-catenin pathway.桥粒芯糖蛋白3(DSG3)通过AKT/糖原合成酶激酶3β/β-连环蛋白信号通路促进膀胱癌的生长和转移。
J Transl Med. 2025 Jul 2;23(1):729. doi: 10.1186/s12967-025-06754-2.
8
POC1A induces epithelial-mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer.POC1A通过STAT3信号通路诱导三阴性乳腺癌发生上皮-间质转化,从而促进肿瘤生长和转移。
Mol Med. 2025 Aug 19;31(1):280. doi: 10.1186/s10020-025-01315-1.
9
Differential Effects of Snail-KO in Human Breast Epithelial Cells and Human Breast Epithelial × Human Breast Cancer Hybrids.蜗牛基因敲除对人乳腺上皮细胞和人乳腺上皮×人乳腺癌杂交细胞的不同影响。
Int J Mol Sci. 2025 Jul 22;26(15):7033. doi: 10.3390/ijms26157033.
10
Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.Toll 样受体 3 介导体干扰素-β 的产生受抑瘤素 m 和更广泛的上皮-间充质转化程序的抑制。
Breast Cancer Res. 2024 Nov 26;26(1):167. doi: 10.1186/s13058-024-01918-2.

本文引用的文献

1
Intraductal photothermal ablation: a noninvasive approach for early breast cancer treatment and prevention.管内光热消融:一种用于早期乳腺癌治疗和预防的非侵入性方法。
Theranostics. 2024 Jul 1;14(10):3997-4013. doi: 10.7150/thno.97968. eCollection 2024.
2
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.TBCRC 039:术前 ruxolitinib 联合或不联合紫杉醇治疗三阴性炎性乳腺癌的 II 期研究。
Breast Cancer Res. 2024 Jan 31;26(1):20. doi: 10.1186/s13058-024-01774-0.
3
SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
SIX1 扩增调节乳腺癌中的干性和肿瘤发生。
J Transl Med. 2023 Nov 29;21(1):866. doi: 10.1186/s12967-023-04679-2.
4
Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?癌细胞可塑性、干细胞因子与治疗抵抗:它们如何关联?
Cancer Metastasis Rev. 2024 Mar;43(1):423-440. doi: 10.1007/s10555-023-10144-9. Epub 2023 Oct 5.
5
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.长链非编码 RNA XIST 通过激活促炎的 IL-6/STAT3 信号来调节乳腺癌干细胞。
Oncogene. 2023 May;42(18):1419-1437. doi: 10.1038/s41388-023-02652-3. Epub 2023 Mar 15.
6
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.乳腺肿瘤微环境中的炎症细胞因子串扰。
Int J Mol Sci. 2023 Feb 16;24(4):4002. doi: 10.3390/ijms24044002.
7
Breast cancer heterogeneity and its implication in personalized precision therapy.乳腺癌异质性及其在个性化精准治疗中的意义。
Exp Hematol Oncol. 2023 Jan 9;12(1):3. doi: 10.1186/s40164-022-00363-1.
8
Resveratrol suppresses lung cancer by targeting cancer stem-like cells and regulating tumor microenvironment.白藜芦醇通过靶向癌症干细胞样细胞和调节肿瘤微环境来抑制肺癌。
J Nutr Biochem. 2023 Feb;112:109211. doi: 10.1016/j.jnutbio.2022.109211. Epub 2022 Nov 9.
9
A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells.一种由CAF驱动的TIMP-1/CD63/ITGB1/STAT3反馈环促进乳腺癌细胞的迁移和生长。
Cancers (Basel). 2022 Oct 11;14(20):4983. doi: 10.3390/cancers14204983.
10
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.STAT 家族转录因子在乳腺癌中的作用:发病机制及治疗的机遇与挑战。
Semin Cancer Biol. 2022 Nov;86(Pt 3):84-106. doi: 10.1016/j.semcancer.2022.08.003. Epub 2022 Aug 19.